{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:27:59Z","timestamp":1791959279794,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["2021\/1414"],"award-info":[{"award-number":["2021\/1414"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02584"],"award-info":[{"award-number":["2018-02584"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALF Link\u00f6ping University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast density and estrogen exposure are two major risk factors for breast cancer; however, the underlying biological mechanisms remain incompletely understood. Here, we investigated the extracellular proteomic landscape of normal human breast tissue in situ to define the microenvironment associated with these risk factors. Forty-two postmenopausal women with nondense or dense breasts and 19 premenopausal women underwent microdialysis. We quantified 461 inflammatory proteins in breast tissue and matched subcutaneous fat, enabling discrimination between local and systemic alterations. Breast density was assessed using magnetic resonance imaging. Dense breast tissue exhibited a distinct protein signature characterized by immune-related signaling, altered lipid metabolism, and the extracellular presence of intracellular proteins, consistent with cellular stress and immune modulation, with limited changes in angiogenic and extracellular matrix remodeling proteins. In contrast, estrogen-exposed breasts displayed a proteomic profile dominated by pro-inflammatory cytokines, angiogenic factors, extracellular matrix remodeling proteins, and complement activation, indicative of a dynamic and pro-tumorigenic microenvironment. These findings demonstrate that breast density and estrogen exposure are associated with fundamentally distinct breast microenvironments, both permissive for tumor progression. These breast-specific protein signatures provide mechanistic insight into how these risk factors contribute to cancer development and suggest that effective prevention strategies may require differential targeting.<\/jats:p>","DOI":"10.1038\/s41523-026-01046-4","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:14:07Z","timestamp":1788545647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteomic signatures identify significantly different inflammatory breast tissue microenvironments depending on mammographic density or estrogen exposure"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-3061","authenticated-orcid":false,"given":"Menikae K.","family":"Heenkenda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-2232","authenticated-orcid":false,"given":"Peter","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-0018","authenticated-orcid":false,"given":"Charlotta","family":"Dabrosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"1046_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"1046_CR2","doi-asserted-by":"crossref","unstructured":"Lim S. Y., Yuzhalin A. E., Gordon-Weeks A. N., Muschel R. J. Tumor-infiltrating monocytes\/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells. Oncogene. 2016.","DOI":"10.1038\/onc.2016.107"},{"key":"1046_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature16140","volume":"528","author":"SK Wculek","year":"2015","unstructured":"Wculek, S. K. & Malanchi, I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528, 413\u2013417 (2015).","journal-title":"Nature"},{"key":"1046_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1158\/0008-5472.CAN-10-2289","volume":"71","author":"G Lindahl","year":"2011","unstructured":"Lindahl, G., Saarinen, N., Abrahamsson, A. & Dabrosin, C. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer. Cancer Res. 71, 51\u201360 (2011).","journal-title":"Cancer Res."},{"key":"1046_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill, F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 9, 361\u2013371 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"1046_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2016.217","volume":"36","author":"PF Yu","year":"2017","unstructured":"Yu, P. F. et al. TNFalpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2(+) neutrophils. Oncogene 36, 482\u2013490 (2017).","journal-title":"Oncogene"},{"key":"1046_CR7","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"1046_CR8","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1677\/erc.1.01038","volume":"12","author":"R Kaaks","year":"2005","unstructured":"Kaaks, R. et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr. Relat. Cancer 12, 1071\u20131082 (2005).","journal-title":"Endocr. Relat. Cancer"},{"key":"1046_CR9","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/jnci\/djq239","volume":"102","author":"NF Boyd","year":"2010","unstructured":"Boyd, N. F. et al. Breast tissue composition and susceptibility to breast cancer. J. Natl. Cancer Inst. 102, 1224\u20131237 (2010).","journal-title":"J. Natl. Cancer Inst."},{"key":"1046_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/bjc.1982.213","volume":"46","author":"TJ Anderson","year":"1982","unstructured":"Anderson, T. J., Ferguson, D. J. & Raab, G. M. Cell turnover in the \u201cresting\u201d human breast: influence of parity, contraceptive pill, age and laterality. Br. J. Cancer 46, 376\u2013382 (1982).","journal-title":"Br. J. Cancer"},{"key":"1046_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1677\/erc.1.01165","volume":"13","author":"CL Wilson","year":"2006","unstructured":"Wilson, C. L., Sims, A. H., Howell, A., Miller, C. J. & Clarke, R. B. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr. Relat. Cancer 13, 617\u2013628 (2006).","journal-title":"Endocr. Relat. Cancer"},{"key":"1046_CR12","first-page":"1320","volume":"61","author":"MP Shekhar","year":"2001","unstructured":"Shekhar, M. P., Werdell, J., Santner, S. J., Pauley, R. J. & Tait, L. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res. 61, 1320\u20131326 (2001).","journal-title":"Cancer Res."},{"key":"1046_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4049\/jimmunol.182.1.371","volume":"182","author":"C Bendrik","year":"2009","unstructured":"Bendrik, C. & Dabrosin, C. Estradiol increases IL-8 secretion of normal human breast tissue and breast cancer in vivo. J. Immunol. 182, 371\u2013378 (2009).","journal-title":"J. Immunol."},{"key":"1046_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00441-006-0159-7","volume":"325","author":"S Garvin","year":"2006","unstructured":"Garvin, S., Nilsson, U. W., Huss, F. R., Kratz, G. & Dabrosin, C. Estradiol increases VEGF in human breast studied by whole-tissue culture. Cell Tissue Res. 325, 245\u2013251 (2006).","journal-title":"Cell Tissue Res."},{"key":"1046_CR15","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1158\/1078-0432.CCR-15-0204","volume":"21","author":"S Svensson","year":"2015","unstructured":"Svensson, S. et al. CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer. Clin. Cancer Res 21, 3794\u20133805 (2015).","journal-title":"Clin. Cancer Res"},{"key":"1046_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/2326-6066.CIR-16-0150","volume":"5","author":"G Vazquez Rodriguez","year":"2017","unstructured":"Vazquez Rodriguez, G., Abrahamsson, A., Jensen, L. D. & Dabrosin, C. Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils. Cancer Immunol. Res. 5, 234\u2013247 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"1046_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000100444","volume":"71","author":"RT Chlebowski","year":"2006","unstructured":"Chlebowski, R. T. & Geller, M. L. Adherence to endocrine therapy for breast cancer. Oncology 71, 1\u20139 (2006).","journal-title":"Oncology"},{"key":"1046_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1408","volume":"8","author":"D Hawes","year":"2006","unstructured":"Hawes, D. et al. Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res. 8, R24 (2006).","journal-title":"Breast Cancer Res."},{"key":"1046_CR19","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/bcr622","volume":"5","author":"S Alowami","year":"2003","unstructured":"Alowami, S., Troup, S., Al-Haddad, S., Kirkpatrick, I. & Watson, P. H. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res. 5, R129\u201335 (2003).","journal-title":"Breast Cancer Res."},{"key":"1046_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1683","volume":"9","author":"QJ Khan","year":"2007","unstructured":"Khan, Q. J. et al. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Res. 9, R35 (2007).","journal-title":"Breast Cancer Res."},{"key":"1046_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.7326\/0003-4819-127-11-199712010-00014","volume":"127","author":"HG Welch","year":"1997","unstructured":"Welch, H. G. & Black, W. C. Using autopsy series to estimate the disease \u201creservoir\u201d for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann. Intern Med 127, 1023\u20131028 (1997).","journal-title":"Ann. Intern Med"},{"key":"1046_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3570","volume":"15","author":"KA Bertrand","year":"2013","unstructured":"Bertrand, K. A. et al. Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res 15, R104 (2013).","journal-title":"Breast Cancer Res"},{"key":"1046_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","volume":"30","author":"J Kim","year":"2019","unstructured":"Kim, J. & DeBerardinis, R. J. Mechanisms and Implications of Metabolic Heterogeneity in Cancer. Cell Metab. 30, 434\u2013446 (2019).","journal-title":"Cell Metab."},{"key":"1046_CR24","doi-asserted-by":"crossref","unstructured":"Kong T., Ma C. X. Unraveling TIME: CD8+ T cell- and CXCL11-driven endocrine resistance in breast cancer. J Clin Invest. 2026;136.","DOI":"10.1172\/JCI200923"},{"key":"1046_CR25","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1007\/s12094-025-03874-5","volume":"27","author":"LB Kwantwi","year":"2025","unstructured":"Kwantwi, L. B., Boafo, J. D., Egleh, B. E. & Li, M. CCL20 in the tumor microenvironment: implications for cancer progression and therapeutic approaches. Clin. Transl. Oncol. 27, 3285\u20133292 (2025).","journal-title":"Clin. Transl. Oncol."},{"key":"1046_CR26","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41416-024-02858-6","volume":"131","author":"C Castro-Espin","year":"2024","unstructured":"Castro-Espin, C. et al. Prognostic role of pre-diagnostic circulating inflammatory biomarkers in breast cancer survival: evidence from the EPIC cohort study. Br. J. Cancer 131, 1496\u20131505 (2024).","journal-title":"Br. J. Cancer"},{"key":"1046_CR27","doi-asserted-by":"crossref","unstructured":"Darwish N. M., et al. The Role of Apolipoproteins in the Commonest Cancers: A Review. Cancers (Basel). 2023;15.","DOI":"10.3390\/cancers15235565"},{"key":"1046_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03985-1","volume":"12","author":"J Lin","year":"2021","unstructured":"Lin, J. et al. Oncogene APOL1 promotes proliferation and inhibits apoptosis via activating NOTCH1 signaling pathway in pancreatic cancer. Cell Death Dis. 12, 760 (2021).","journal-title":"Cell Death Dis."},{"key":"1046_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang, B., Song, B. L. & Xu, C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat. Metab. 2, 132\u2013141 (2020).","journal-title":"Nat. Metab."},{"key":"1046_CR30","doi-asserted-by":"publisher","first-page":"15959","DOI":"10.1007\/s13277-016-5453-8","volume":"37","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. Serum levels of apolipoprotein E correlates with disease progression and poor prognosis in breast cancer. Tumour Biol. 37, 15959\u201315966 (2016).","journal-title":"Tumour Biol."},{"key":"1046_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1232227","volume":"339","author":"LM Coussens","year":"2013","unstructured":"Coussens, L. M., Zitvogel, L. & Palucka, A. K. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339, 286\u2013291 (2013).","journal-title":"Science"},{"key":"1046_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436\u2013444 (2008).","journal-title":"Nature"},{"key":"1046_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10911-023-09552-y","volume":"28","author":"N Giotopoulou","year":"2023","unstructured":"Giotopoulou, N., Shi, W., Parniewska, M. M., Sun, W. & Fuxe, J. TGFss1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for Breast Cancer Cells with Mesenchymal Properties. J. Mammary Gland Biol. Neoplasia 28, 25 (2023).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"1046_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01812-x","volume":"26","author":"P Karihtala","year":"2024","unstructured":"Karihtala, P. et al. Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival. Breast Cancer Res. 26, 61 (2024).","journal-title":"Breast Cancer Res."},{"key":"1046_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1449668","volume":"15","author":"J Song","year":"2024","unstructured":"Song, J. & Yang, H. Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis. Front Endocrinol. (Lausanne) 15, 1449668 (2024).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"1046_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S1470-2045(00)00323-5","volume":"2","author":"SB Fox","year":"2001","unstructured":"Fox, S. B., Gasparini, G. & Harris, A. L. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol. 2, 278\u2013289 (2001).","journal-title":"Lancet Oncol."},{"key":"1046_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","volume":"22","author":"Y Cao","year":"2023","unstructured":"Cao, Y., Langer, R. & Ferrara, N. Targeting angiogenesis in oncology, ophthalmology and beyond. Nat. Rev. Drug Discov. 22, 476\u2013495 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1046_CR38","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1172\/JCI90962","volume":"127","author":"V Afshar-Kharghan","year":"2017","unstructured":"Afshar-Kharghan, V. The role of the complement system in cancer. J. Clin. Invest 127, 780\u2013789 (2017).","journal-title":"J. Clin. Invest"},{"key":"1046_CR39","unstructured":"Sickles E., et al. ACR BI-RADS\u00ae Mammography. In: ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting and Data System. Reston, VA: American College of Radiology; 2013."},{"key":"1046_CR40","doi-asserted-by":"publisher","first-page":"e1229723","DOI":"10.1080\/2162402X.2016.1229723","volume":"5","author":"A Abrahamsson","year":"2016","unstructured":"Abrahamsson, A. et al. Dense breast tissue in postmenopausal women is associated with a pro-inflammatory microenvironment in vivo. Oncoimmunology 5, e1229723 (2016).","journal-title":"Oncoimmunology"},{"key":"1046_CR41","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41416-022-01976-3","volume":"127","author":"P Lundberg","year":"2022","unstructured":"Lundberg, P. et al. Breast density is strongly associated with multiparametric magnetic resonance imaging biomarkers and pro-tumorigenic proteins in situ. Br. J. Cancer 127, 2025\u20132033 (2022).","journal-title":"Br. J. Cancer"},{"key":"1046_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850240","volume":"13","author":"J Ekstrand","year":"2022","unstructured":"Ekstrand, J. et al. Breast Density and Estradiol Are Major Determinants for Soluble TNF-TNF-R Proteins in vivo in Human Breast Tissue. Front Immunol. 13, 850240 (2022).","journal-title":"Front Immunol."},{"key":"1046_CR43","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/mrm.21737","volume":"60","author":"H Yu","year":"2008","unstructured":"Yu, H. et al. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn. Reson Med 60, 1122\u20131134 (2008).","journal-title":"Magn. Reson Med"},{"key":"1046_CR44","doi-asserted-by":"publisher","first-page":"e25720","DOI":"10.1371\/journal.pone.0025720","volume":"6","author":"UW Aberg","year":"2011","unstructured":"Aberg, U. W. et al. Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo. PLoS One 6, e25720 (2011).","journal-title":"PLoS One"},{"key":"1046_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1023\/A:1024575103524","volume":"80","author":"C Dabrosin","year":"2003","unstructured":"Dabrosin, C. Increase of free insulin-like growth factor-1 in normal human breast in vivo late in the menstrual cycle. Breast Cancer Res. Treat. 80, 193\u2013198 (2003).","journal-title":"Breast Cancer Res. Treat."},{"key":"1046_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1677\/joe.1.06163","volume":"187","author":"C Dabrosin","year":"2005","unstructured":"Dabrosin, C. Increased extracellular local levels of estradiol in normal breast in vivo during the luteal phase of the menstrual cycle. J. Endocrinol. 187, 103\u2013108 (2005).","journal-title":"J. Endocrinol."},{"key":"1046_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10456-005-9002-0","volume":"8","author":"C Dabrosin","year":"2005","unstructured":"Dabrosin, C. Sex steroid regulation of angiogenesis in breast tissue. Angiogenesis 8, 127\u2013136 (2005).","journal-title":"Angiogenesis"},{"key":"1046_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-73","volume":"8","author":"S Garvin","year":"2008","unstructured":"Garvin, S. & Dabrosin, C. In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients. BMC Cancer 8, 73 (2008).","journal-title":"BMC Cancer"},{"key":"1046_CR49","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1158\/1078-0432.CCR-10-0501","volume":"16","author":"UW Nilsson","year":"2010","unstructured":"Nilsson, U. W., Abrahamsson, A. & Dabrosin, C. Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo. Clin. Cancer Res. 16, 3659\u20133669 (2010).","journal-title":"Clin. Cancer Res."},{"key":"1046_CR50","doi-asserted-by":"publisher","first-page":"22959","DOI":"10.18632\/oncotarget.4038","volume":"6","author":"A Abrahamsson","year":"2015","unstructured":"Abrahamsson, A. & Dabrosin, C. Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo. Oncotarget 6, 22959\u201322969 (2015).","journal-title":"Oncotarget"},{"key":"1046_CR51","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1042\/cs0920493","volume":"92","author":"C Dabrosin","year":"1997","unstructured":"Dabrosin, C., Hallstrom, A., Ungerstedt, U. & Hammar, M. Microdialysis of human breast tissue during the menstrual cycle. Clin. Sci. (Lond.) 92, 493\u2013496 (1997).","journal-title":"Clin. Sci. (Lond.)"},{"key":"1046_CR52","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1158\/0008-5472.CAN-20-1705","volume":"80","author":"A Abrahamsson","year":"2020","unstructured":"Abrahamsson, A., Rodriguez, G. V. & Dabrosin, C. Fulvestrant-Mediated Attenuation of the Innate Immune Response Decreases ER(+) Breast Cancer Growth In Vivo More Effectively than Tamoxifen. Cancer Res. 80, 4487\u20134499 (2020).","journal-title":"Cancer Res."},{"key":"1046_CR53","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3389\/fimmu.2017.01994","volume":"8","author":"A Abrahamsson","year":"2017","unstructured":"Abrahamsson, A., Rzepecka, A. & Dabrosin, C. Equal Pro-inflammatory Profiles of CCLs, CXCLs, and Matrix Metalloproteinases in the Extracellular Microenvironment In Vivo in Human Dense Breast Tissue and Breast Cancer. Front Immunol. 8, 1994 (2017).","journal-title":"Front Immunol."},{"key":"1046_CR54","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/clinem\/dgaa820","volume":"106","author":"S Mijic","year":"2021","unstructured":"Mijic, S. & Dabrosin, C. Platelet Activation In Situ in Breasts at High Risk of Cancer: Relationship with Mammographic Density and Estradiol. J. Clin. Endocrinol. Metab. 106, 485\u2013500 (2021).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01046-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01046-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01046-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:21:13Z","timestamp":1788546073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01046-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-01046-4","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"118"}}